<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05077943</url>
  </required_header>
  <id_info>
    <org_study_id>Home based Exercise PostCovid</org_study_id>
    <nct_id>NCT05077943</nct_id>
  </id_info>
  <brief_title>The Effect of Home-based Exercise on Functional Capacity of Covid-19 Survivor With Cardiovascular Comorbidity</brief_title>
  <official_title>The Effect of Home-based Breathing and Chest Mobilisation Exercise on Cardiorespiratory Functional Capacity of Covid-19 Survivor With Cardiovascular Comorbidity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cardiovascular Center Harapan Kita Hospital Indonesia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cardiovascular Center Harapan Kita Hospital Indonesia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective propose: to investigate the effect of home based breathing exercise and chest&#xD;
      mobilization on the cardiorespiratory functional capacity of Covid-19 survivors with&#xD;
      cardiovascular comorbidity.&#xD;
&#xD;
      Breathing exercise and chest mobilization are proven to increase lung functional capacity in&#xD;
      Covid-19 survivors. It is hypothesized that breathing exercise and chest mobilization in&#xD;
      Covid-19 survivors will give benefits to Covid-19 survivors with cardiovascular disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lung restrictive disorder is one of the reasons that induce chronic fatigue in COVID-19&#xD;
      (Corona Virus Disease-19) survivors. It also gives a significant effect on cardiovascular&#xD;
      patients who are in the second phase of cardiac rehabilitation. Breathing exercise and chest&#xD;
      mobilization are proven to increase lung functional capacity in Covid-19 survivors. On the&#xD;
      other hand, there is still no research that shows the effectiveness of Breathing exercises&#xD;
      and chest mobilization in Covid-19 survivors who are suffering from cardiovascular problems.&#xD;
&#xD;
      Patients in National Cardiac Center Hospital, Jakarta, with a history of Covid-19 and have&#xD;
      cardiovascular disease are recruited. They will undergo pre and post-exercise examinations&#xD;
      such as blood sampling, do 6 minutes walking test, Peak Cough Flow and Peak Flow Rate test,&#xD;
      measuring the chest dimension, treadmill, and answer the European Quality of Life Five&#xD;
      Dimension (EQ-5D) questions. With randomization, patients will be determined to treatment or&#xD;
      control group. They will be prepared about what exercises should they do at home. Subjects&#xD;
      will be supervised digitally and regularly through Zoom meetings. Exercises will be done for&#xD;
      3 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Peak Cough Flow (PC)</measure>
    <time_frame>Change from Baseline Peak Cough Flow (PC) at 3 months</time_frame>
    <description>to define the functional capacity. Unit of measure : L/min.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Peak Flow Rate (PFR)</measure>
    <time_frame>Change from Baseline Peak Flow Rate (PFR) at 3 months</time_frame>
    <description>to define the functional capacity. Unit of measure : L/min.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Cardiac Exercise Test</measure>
    <time_frame>Change from Baseline Cardiac Exercise Test at 3 months</time_frame>
    <description>Patients walk on treadmill. Unit of measure : minutes, METs (Metabolic Equivalent of Task)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of 6-minutes walking test</measure>
    <time_frame>Change from Baseline 6-minutes walking test at 3 months</time_frame>
    <description>To define initial ability to walk in 30 minutes for second phase cardiac rehabilitation (aerobic exercise). Unit of measure : meter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Hemoglobin</measure>
    <time_frame>Change from Baseline Hemoglobin at 3 months</time_frame>
    <description>Hemoglobin (g/dL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Hematocrit</measure>
    <time_frame>Change from Baseline Hematocrit at 3 months</time_frame>
    <description>Hematocrit (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Erythrocyte</measure>
    <time_frame>Change from Baseline Erythrocyte at 3 months</time_frame>
    <description>Erythrocyte (million/µL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Mean Corpuscular Volume</measure>
    <time_frame>Change from Baseline Mean Corpuscular Volume at 3 months</time_frame>
    <description>Mean Corpuscular Volume (fL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Mean Corpuscular Hemoglobin</measure>
    <time_frame>Change from Baseline Mean Corpuscular Hemoglobin at 3 months</time_frame>
    <description>Mean Corpuscular Hemoglobin (pg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Mean Corpuscular Hemoglobin Concentration</measure>
    <time_frame>Change from Baseline Mean Corpuscular Hemoglobin Concentration at 3 months</time_frame>
    <description>Mean Corpuscular Hemoglobin Concentration (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Red Cell Distribution Width</measure>
    <time_frame>Change from Baseline Red Cell Distribution Width at 3 months</time_frame>
    <description>Red Cell Distribution Width (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Leucocyte</measure>
    <time_frame>Change from Baseline Leucocyte at 3 months</time_frame>
    <description>Leucocyte (/µL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Platelet</measure>
    <time_frame>Change from Baseline Platelet at 3 months</time_frame>
    <description>Platelet (thousand/µL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of European Quality of Life Five Dimension (EQ-5D)</measure>
    <time_frame>Change from Baseline EQ-5D at 3 months</time_frame>
    <description>1=have no problem, 2=have slight problem, 3=moderate problem, 4=severe problem, 5=unable to do. We will compare the points between pre and post exercise and looking the improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Basophil</measure>
    <time_frame>Change from Baseline Basophil at 3 months</time_frame>
    <description>Basophil (/µL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Eosinophil</measure>
    <time_frame>Change from Baseline Eosinophil at 3 months</time_frame>
    <description>Eosinophil (/µL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Neutrophil</measure>
    <time_frame>Change from Baseline Neutrophil at 3 months</time_frame>
    <description>Neutrophil (/µL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Lymphocyte</measure>
    <time_frame>Change from Baseline Lymphocyte at 3 months</time_frame>
    <description>Lymphocyte (/µL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Monocyte</measure>
    <time_frame>Change from Baseline Monocyte at 3 months</time_frame>
    <description>Monocyte (/µL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of C-Reactive Protein</measure>
    <time_frame>Change from Baseline C-Reactive Protein at 3 months</time_frame>
    <description>to determine infection markers. Unit of measure : mg/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of D-dimer</measure>
    <time_frame>Change from Baseline D-dimer at 3 months</time_frame>
    <description>Unit of measure : ng/mL</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Covid19</condition>
  <condition>Breathing Exercise</condition>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>No Breathing Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will do the second phase of cardiac rehabilitation for minimum 5 times per week, 30 minutes each time, in 3 months without being supervised</description>
  </arm_group>
  <arm_group>
    <arm_group_label>With Breathing Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will do the second phase of cardiac rehabilitation for minimum 5 times per week, 30 minutes each time and breathing and chest mobilization exercise for 3 times per week. They will be supervised through online meetings.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Breathing and chest mobilization exercises</intervention_name>
    <description>Patients walk regularly 5 times per week and increase the distance day by day according to their improved ability. Patients also do breathing and chest mobilization exercise 3 times per week. It is a recorded moderated exercise for 30 minutes duration. Patients can access the video as a home-based activity through an online videos platform and will be supervised.</description>
    <arm_group_label>With Breathing Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Second phase cardiac rehabilitation</intervention_name>
    <description>Independently, patients walk regularly 5 times per week and increase the distance day by day according to their improved ability without breathing and chest mobilization exercise.</description>
    <arm_group_label>No Breathing Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who got infected by Covid-19 in 3 months before recruitment and suffering&#xD;
             cardiovascular disease&#xD;
&#xD;
          -  Able to communicate and operate Youtube and Zoom.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Limitation to move any part of the body that causes the inability to do the instructed&#xD;
             exercise.&#xD;
&#xD;
          -  Feel pain in extremities (visual analog scale &gt;3)&#xD;
&#xD;
          -  Chronic Obstructive Pulmonary Disease&#xD;
&#xD;
          -  Neuromuscular disorder (stroke, peripheral neuropathy with significant motoric control&#xD;
             disturbance&#xD;
&#xD;
          -  Musculoskeletal disorder (fracture, post amputation, severe arthritis in support&#xD;
             joints)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bambang Dwiputra, MD, FIHA</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cardiovascular Center Harapan Kita Hospital Indonesia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bambang Dwiputra, MD, FIHA</last_name>
    <phone>021-5684085</phone>
    <phone_ext>2209</phone_ext>
    <email>bambangdwiputra@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kevin Triangto, MD</last_name>
    <email>kevintriangto14@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Cardiovascular Center Harapan Kita Hospital Indonesia</name>
      <address>
        <city>Jakarta</city>
        <zip>11420</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bambang Dwiputra, MD, FIHA</last_name>
      <phone>021-5684085</phone>
      <phone_ext>2209</phone_ext>
      <email>bambangdwiputra@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Kevin Triangto, MD</last_name>
      <phone>021-5684085</phone>
      <phone_ext>2209</phone_ext>
      <email>kevintriangto14@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <reference>
    <citation>1. WHO Indonesia. Coronavirus Disease 2019 (COVID-19) Situation Report-36. [Internet]. WHO; [2020 Dec 2; cited 2021 Feb 12]. Available from: https://www.who.int/indonesia/news/novel-coronavirus/situation-reports</citation>
  </reference>
  <reference>
    <citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O'Connor RJ, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021 Feb;93(2):1013-1022. doi: 10.1002/jmv.26368. Epub 2020 Aug 17.</citation>
    <PMID>32729939</PMID>
  </reference>
  <reference>
    <citation>Eapen MS, Lu W, Gaikwad AV, Bhattarai P, Chia C, Hardikar A, Haug G, Sohal SS. Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Eur Respir J. 2020 Oct 15;56(4). pii: 2003167. doi: 10.1183/13993003.03167-2020. Print 2020 Oct.</citation>
    <PMID>32859681</PMID>
  </reference>
  <reference>
    <citation>Abdullahi A. Safety and Efficacy of Chest Physiotherapy in Patients With COVID-19: A Critical Review. Front Med (Lausanne). 2020 Jul 21;7:454. doi: 10.3389/fmed.2020.00454. eCollection 2020. Review.</citation>
    <PMID>32793618</PMID>
  </reference>
  <reference>
    <citation>Sardari A, Tabarsi P, Borhany H, Mohiaddin R, Houshmand G. Myocarditis detected after COVID-19 recovery. Eur Heart J Cardiovasc Imaging. 2021 Jan 1;22(1):131-132. doi: 10.1093/ehjci/jeaa166.</citation>
    <PMID>32462177</PMID>
  </reference>
  <reference>
    <citation>Salman D, Vishnubala D, Le Feuvre P, Beaney T, Korgaonkar J, Majeed A, McGregor AH. Returning to physical activity after covid-19. BMJ. 2021 Jan 8;372:m4721. doi: 10.1136/bmj.m4721.</citation>
    <PMID>33419740</PMID>
  </reference>
  <reference>
    <citation>Ogura A, Izawa KP, Tawa H, Kureha F, Wada M, Harada N, Ikeda Y, Kimura K, Kondo N, Kanai M, Kubo I, Yoshikawa R, Matsuda Y. Impact of the COVID-19 pandemic on phase 2 cardiac rehabilitation patients in Japan. Heart Vessels. 2021 Aug;36(8):1184-1189. doi: 10.1007/s00380-021-01783-5. Epub 2021 Jan 29.</citation>
    <PMID>33512598</PMID>
  </reference>
  <reference>
    <citation>Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020 Aug;54(16):949-959. doi: 10.1136/bjsports-2020-102596. Epub 2020 May 31.</citation>
    <PMID>32475821</PMID>
  </reference>
  <reference>
    <citation>9. ESC. Recommendations on how to provide cardiac rehabilitation activities during the COVID-19 pandemic. [Internet] France: European Society of Cardiology; [2020 Apr 8; cited in 2021 Feb 12]. Available from: https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/recommendations-on-how-to-provide-cardiac-rehabilitation-activities-during-the-c</citation>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 29, 2021</study_first_submitted>
  <study_first_submitted_qc>October 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cardiovascular Center Harapan Kita Hospital Indonesia</investigator_affiliation>
    <investigator_full_name>Bambang Dwiputra, MD</investigator_full_name>
    <investigator_title>MD Cardiologist, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

